Parameters | Overall | CECS | EES | P |
---|---|---|---|---|
EOR (%) | Â | Â | Â | 0.0001 |
 GTR | 21 (42.0%) | 18 (66.7%) | 3 (13.0%) |  |
 NTR | 19 (38.0%) | 9 (33.3%) | 10 (43.5%) |  |
 STR | 6 (12.0%) | 0 (0%) | 6 (26.1%) |  |
 PR | 4 (8.0%) | 0 (0%) | 4 (17.4%) |  |
Intraope blood loss, ml (IQR) | 400 (200–650) | 450 (300–1000) | 300(150–500) | 0.002 |
Operation time, h | 5.93 ± 2.13 | 7.3 ± 1.8 | 4.3 ± 1.2 | 0.0001 |
Postop Hospital days, d (IQR) | 15 (9–20) | 15 (14–21) | 11(7–20) | 0.092 |
Hospital days, d (IQR) | 24 (17.7–30) | 26 (22–32) | 20(14–29) | 0.063 |
Periop complications (%) | ||||
 Intracranial infection | 18 (36.0%) | 9 (33.3%) | 9 (39.1%) | 0.670 |
 CSF leakage | 3 (6.0%) | 1 (3.7%) | 2 (8.7%) | 0.459 |
 New pituitary dysfunction | 24 (48.0%) | 14 (51.9%) | 10 (43.5%) | 0.555 |
 Postoperative diabetes insipidus | 15 (30.0%) | 6 (22.2%) | 9 (39.1%) | 0.193 |
 Oculomotor nerve paralysis | 6 (12.0%) | 2 (7.4%) | 4 (17.4%) | 0.279 |
 Postoperative bleeding | 21 (42.0%) | 2 (7.4%) | 15 (65.2%) | 0.0001 |
 Vascular infarction | 3 (6.0%) | 1 (3.7%) | 2 (8.7%) | 0.459 |
 Periop mortality | 1 (2.0%) | 0 (0%) | 1 (4.3%) | 0.274 |